JNJ
Price
$158.01
Change
+$2.23 (+1.43%)
Updated
Mar 27, 6:59 PM EST
19 days until earnings call
PFE
Price
$27.77
Change
+$0.18 (+0.65%)
Updated
Mar 27, 6:59 PM EST
34 days until earnings call
Ad is loading...

Compare trend and price JNJ vs PFE

Header iconJNJ vs PFE Comparison
Open Charts JNJ vs PFEBanner chart's image
Johnson & Johnson
Price$158.01
Change+$2.23 (+1.43%)
Volume$2.8M
CapitalizationN/A
Pfizer
Price$27.77
Change+$0.18 (+0.65%)
Volume$13.61M
CapitalizationN/A
View a ticker or compare two or three
JNJ vs PFE Comparison Chart

Loading...

JNJDaily Signal changed days agoGain/Loss if shorted
 
Show more...
PFEDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
JNJ vs. PFE commentary
Mar 28, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JNJ is a StrongBuy and PFE is a Buy.

COMPARISON
Comparison
Mar 28, 2024
Stock price -- (JNJ: $157.96 vs. PFE: $27.78)
Brand notoriety: JNJ and PFE are both notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: JNJ: 117% vs. PFE: 77%
Market capitalization -- JNJ: $380.65B vs. PFE: $157.31B
JNJ [@Pharmaceuticals: Major] is valued at $380.65B. PFE’s [@Pharmaceuticals: Major] market capitalization is $157.31B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.87B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $87.5B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JNJ’s FA Score shows that 4 FA rating(s) are green whilePFE’s FA Score has 2 green FA rating(s).

  • JNJ’s FA Score: 4 green, 1 red.
  • PFE’s FA Score: 2 green, 3 red.
According to our system of comparison, JNJ is a better buy in the long-term than PFE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JNJ’s TA Score shows that 4 TA indicator(s) are bullish while PFE’s TA Score has 6 bullish TA indicator(s).

  • JNJ’s TA Score: 4 bullish, 6 bearish.
  • PFE’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, PFE is a better buy in the short-term than JNJ.

Price Growth

JNJ (@Pharmaceuticals: Major) experienced а +1.41% price change this week, while PFE (@Pharmaceuticals: Major) price change was +0.29% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.63%. For the same industry, the average monthly price growth was -2.85%, and the average quarterly price growth was -2.15%.

Reported Earning Dates

JNJ is expected to report earnings on Apr 16, 2024.

PFE is expected to report earnings on May 01, 2024.

Industries' Descriptions

@Pharmaceuticals: Major (+0.63% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
A.I.dvisor published
a Summary for JNJ with price predictions.
OPEN
A.I.dvisor published
a Summary for PFE with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
JNJ($381B) has a higher market cap than PFE($157B). PFE has higher P/E ratio than JNJ: PFE (75.08) vs JNJ (30.38). JNJ YTD gains are higher at: 1.543 vs. PFE (-2.056). JNJ has higher annual earnings (EBITDA): 23.3B vs. PFE (9.56B). JNJ has more cash in the bank: 22.9B vs. PFE (12.7B). JNJ has less debt than PFE: JNJ (29.3B) vs PFE (70.8B). JNJ has higher revenues than PFE: JNJ (85.2B) vs PFE (58.5B).
JNJPFEJNJ / PFE
Capitalization381B157B243%
EBITDA23.3B9.56B244%
Gain YTD1.543-2.056-75%
P/E Ratio30.3875.0840%
Revenue85.2B58.5B146%
Total Cash22.9B12.7B180%
Total Debt29.3B70.8B41%
FUNDAMENTALS RATINGS
JNJ vs PFE: Fundamental Ratings
JNJ
PFE
OUTLOOK RATING
1..100
5468
VALUATION
overvalued / fair valued / undervalued
1..100
12
Undervalued
4
Undervalued
PROFIT vs RISK RATING
1..100
31100
SMR RATING
1..100
2088
PRICE GROWTH RATING
1..100
5561
P/E GROWTH RATING
1..100
331
SEASONALITY SCORE
1..100
7550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PFE's Valuation (4) in the Pharmaceuticals Major industry is in the same range as JNJ (12). This means that PFE’s stock grew similarly to JNJ’s over the last 12 months.

JNJ's Profit vs Risk Rating (31) in the Pharmaceuticals Major industry is significantly better than the same rating for PFE (100). This means that JNJ’s stock grew significantly faster than PFE’s over the last 12 months.

JNJ's SMR Rating (20) in the Pharmaceuticals Major industry is significantly better than the same rating for PFE (88). This means that JNJ’s stock grew significantly faster than PFE’s over the last 12 months.

JNJ's Price Growth Rating (55) in the Pharmaceuticals Major industry is in the same range as PFE (61). This means that JNJ’s stock grew similarly to PFE’s over the last 12 months.

PFE's P/E Growth Rating (1) in the Pharmaceuticals Major industry is in the same range as JNJ (33). This means that PFE’s stock grew similarly to JNJ’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
JNJPFE
RSI
ODDS (%)
Bearish Trend 1 day ago
53%
Bullish Trend 1 day ago
62%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
56%
Bullish Trend 1 day ago
54%
Momentum
ODDS (%)
Bearish Trend 1 day ago
38%
Bearish Trend 1 day ago
71%
MACD
ODDS (%)
Bearish Trend 1 day ago
34%
Bullish Trend 1 day ago
62%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
43%
Bullish Trend 1 day ago
57%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
40%
Bullish Trend 1 day ago
51%
Advances
ODDS (%)
Bullish Trend 1 day ago
43%
Bullish Trend 1 day ago
55%
Declines
ODDS (%)
Bearish Trend 4 days ago
43%
Bearish Trend 7 days ago
63%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
68%
Bearish Trend 1 day ago
50%
Aroon
ODDS (%)
Bullish Trend 1 day ago
39%
Bearish Trend 1 day ago
54%
View a ticker or compare two or three
Ad is loading...
JNJDaily Signal changed days agoGain/Loss if shorted
 
Show more...
PFEDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VLY7.900.29
+3.81%
Valley National Bancorp
HOFT23.550.63
+2.75%
Hooker Furnishings Corp
CTSH73.621.22
+1.69%
Cognizant Technology Solutions Corp
LOMA6.82-0.09
-1.30%
Loma Negra Compania Industrial Argentina Sociedad Anonima
APTO1.50-0.10
-6.19%
Aptose Biosciences

JNJ and

Correlation & Price change

A.I.dvisor indicates that over the last year, JNJ has been loosely correlated with PFE. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if JNJ jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JNJ
1D Price
Change %
JNJ100%
+1.41%
PFE - JNJ
59%
Loosely correlated
+0.69%
MRK - JNJ
46%
Loosely correlated
+4.96%
BMY - JNJ
37%
Loosely correlated
+1.33%
ABBV - JNJ
37%
Loosely correlated
+0.65%
AMGN - JNJ
35%
Loosely correlated
+1.61%
More

PFE and

Correlation & Price change

A.I.dvisor indicates that over the last year, PFE has been loosely correlated with MRK. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if PFE jumps, then MRK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PFE
1D Price
Change %
PFE100%
+0.69%
MRK - PFE
38%
Loosely correlated
+4.96%
BMY - PFE
37%
Loosely correlated
+1.33%
JNJ - PFE
28%
Poorly correlated
+1.41%
BIIB - PFE
25%
Poorly correlated
+2.03%
AZN - PFE
24%
Poorly correlated
+2.89%
More